Literature DB >> 31230263

Comment on "Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-center experience from southern India".

Desirée Gianardi1, Gregorio Di Franco2, Matteo Palmeri2, Matteo Bianchini2, Niccolò Furbetta2, Luca Morelli2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31230263     DOI： 10.1007/s12664-019-00967-2

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  7 in total

1.  Everolimus-based immunosuppression in a case of ABO-incompatible liver transplantation with calcineurin inhibitor-related posterior occipital syndrome.

Authors:  Gabriele Catalano; Paolo De Simone; Alessandro Mazzoni; Davide Ghinolfi; Laura Coletti; Franco Filipponi
Journal:  Transpl Int       Date:  2014-03-29       Impact factor: 3.782

2.  Lessons learnt from living donor liver transplantation with ABO-incompatibility: A single-centre experience from southern India.

Authors:  Surumi Shajahan; Sreedurga Thottanchery Sasidharan; Sudhindran Surendran; Veena Shenoy; Uma Devi Padma
Journal:  Indian J Gastroenterol       Date:  2019-03-08

3.  Treatment of antibody-mediated rejection with high-dose immunoglobulins in ABO-incompatible liver transplant recipient.

Authors:  Lucio Urbani; Alessandro Mazzoni; Paolo De Simone; Gabriele Catalano; Laura Coletti; Umberto Montin; Luca Morelli; Daniela Campani; Luca Pollina; Gianni Biancofiore; Lucia Bindi; Fabrizio Scatena; Franco Filipponi
Journal:  Transpl Int       Date:  2007-01-11       Impact factor: 3.782

4.  Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation.

Authors:  Jun Bae Bang; Bong-Wan Kim; Young Bae Kim; Hee-Jung Wang; Hyun Yeong Lee; Joohyun Sim; Taegyu Kim; Kyeong Lok Lee; Xu-Guang Hu; Wei Mao
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

5.  Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.

Authors:  Gi-Won Song; Sung-Gyu Lee; Shin Hwang; Ki-Hum Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Dong-Hwan Jung; Gil-Chun Park; Sung-Hwa Kang; Bo-Hyun Jung; Young-In Yoon; Nayoung Kim
Journal:  J Hepatol       Date:  2014-05-05       Impact factor: 25.083

Review 6.  A systematic review of the use of rituximab for the treatment of antibody-mediated renal transplant rejection.

Authors:  Philip S Macklin; Peter J Morris; Simon R Knight
Journal:  Transplant Rev (Orlando)       Date:  2017-01-24       Impact factor: 3.943

7.  Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.

Authors:  H Egawa; S Teramukai; H Haga; M Tanabe; A Mori; T Ikegami; N Kawagishi; H Ohdan; M Kasahara; K Umeshita
Journal:  Am J Transplant       Date:  2013-11-26       Impact factor: 8.086
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.